Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 1 Diabetes Mellitus Patients (INSTRIDE 1)

ClinicalTrials.gov ID: NCT02227862

Public ClinicalTrials.gov record NCT02227862. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Randomized, Multi-Center, Parallel-Group Clinical Trial Comparing the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 1 Diabetes Mellitus Patients

Study identification

NCT ID
NCT02227862
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Mylan Inc.
Industry
Enrollment
558 participants

Conditions and interventions

Interventions

  • Lantus® Drug
  • Mylan's insulin glargine Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2014
Primary completion
Jun 30, 2016
Completion
Jun 30, 2016
Last update posted
Mar 2, 2022

2014 – 2016

United States locations

U.S. sites
72
U.S. states
22
U.S. cities
67
Facility City State ZIP Site status
Mylan Investigational Site Bell Gardens California 90201
Mylan Investigational Site Fresno California 93720
Mylan Investigational Site Greenbrae California 93720
Mylan Investigational Site La Jolla California 92037
Mylan Investigational Site La Mesa California 91942
Mylan Investigational Site Long Beach California 90807
Mylan Investigational Site Los Gatos California 95032
Mylan Investigational Site Mission Hills California 91345
Mylan Investigational Site National City California 91950
Mylan Investigational Site Northridge California 91324
Mylan Investigational Site Tustin California 92780
Mylan Investigational Site Walnut Creek California 94598
Mylan Investigational Site Bradenton Florida 34208
Mylan Investigational Site Cooper City Florida 33024
Mylan Investigational Site Hialeah Florida 33012
Mylan Investigational Site Hollywood Florida 33021
Mylan Investigational Site Miami Florida 33142
Mylan Investigational Site Miami Florida 33156
Mylan Investigational Site New Port Richey Florida 34652
Mylan Investigational Site Palm Harbor Florida 34684
Mylan Investigational Site West Palm Beach Florida 33401
Mylan Investigational Site Atlanta Georgia 30318
Mylan Investigational Site Columbus Georgia 31904
Mylan Investigational Site Honolulu Hawaii 96814
Mylan Investigational Site Idaho Falls Idaho 83404
Mylan Investigational Site Crystal Lake Illinois 60012
Mylan Investigational Site LaGrange Illinois 60525
Mylan Investigational Site Springfield Illinois 62704
Mylan Investigational Site Anderson Indiana 46011
Mylan Investigational Site Muncie Indiana 47304
Mylan Investigational Site Council Bluffs Iowa 51501
Mylan Investigational Site Des Moines Iowa 50314
Mylan Investigational Site Overland Park Kansas 66210
Mylan Investigational Site Topeka Kansas 66606
Mylan Investigational Site Lexington Kentucky 40503
Mylan Investigational Site Billings Montana 59101
Mylan Investigational Site Omaha Nebraska 68114
Mylan Investigational Site Omaha Nebraska 68131
Mylan Investigational Site Las Vegas Nevada 89128
Mylan Investigational Site Albany New York 12206
Mylan Investigational Site Mineola New York 11501
Mylan Investigational Site Staten Island New York 10301
Mylan Investigational Site Syracuse New York 13210
Mylan Investigational Site Asheville North Carolina 28803
Mylan Investigational Site Burlington North Carolina 27215
Mylan Investigational Site Greensboro North Carolina 27408
Mylan Investigational Site Greenville North Carolina 27834
Mylan Investigational Site Hickory North Carolina 28601
Mylan Investigational Site Morehead City North Carolina 28557
Mylan Investigational Site Wilmington North Carolina 28401
Mylan Investigational Site Cincinnati Ohio 45236
Mylan Investigational Site Mentor Ohio 44060
Mylan Investigational Site Bend Oregon 97701
Mylan Investigational Site Corvallis Oregon 97330
Mylan Investigational Site Chattanooga Tennessee 37411
Mylan Investigational Site Memphis Tennessee 38119
Mylan Investigational Site Austin Texas 78731
Mylan Investigational Site Dallas Texas 75231
Mylan Investigational Site El Paso Texas 79925
Mylan Investigational Site Round Rock Texas 78681
Texas Diabetes & Endocrinology Round Rock Texas 78681
Mylan Investigational Site San Antonio Texas 78258
Mylan Investigational Site Ogden Utah 84405
Mylan Investigational Site Salt Lake City Utah 84102
Mylan Investigational Site Salt Lake City Utah 84109
Mylan Investigational Site Salt Lake City Utah 84121
Mylan Investigational Site South Jordan Utah 84095
Mylan Investigational Site Chesapeake Virginia 23321
Mylan Investigational Site Manassas Virginia 20110
Mylan Investigational Site Renton Washington 98057
Mylan Investigational Site Tacoma Washington 98405
Mylan Investigational Site Vancouver Washington 98664

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 90 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02227862, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 2, 2022 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02227862 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →